Journal retracts Covaxin study after manufacturer sues for defamation

BMJ. 2024 Sep 26:386:q2119. doi: 10.1136/bmj.q2119.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • COVID-19 Drug Treatment
  • COVID-19 Vaccines
  • Drug Industry
  • Humans
  • Periodicals as Topic
  • Retraction of Publication as Topic*
  • SARS-CoV-2
  • Vaccines, Inactivated

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab
  • BBV152 COVID-19 vaccine
  • COVID-19 Vaccines
  • Vaccines, Inactivated